secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLIFE SOLUTIONS INC (BLFS)
CIK:        0000834365
Form:       8-K
Filed at:   2023-10-23T23:59:59+00:00
Accession:  0001628280-23-034923
Event type: leadership
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLife Solutions names Roderick de Greef CEO; prelim Q3 rev $33.3M, FY23 guidance at low end
--------------------------------------------------------------------------------

- Michael Rice resigns as CEO and Chairman; Roderick de Greef appointed President, CEO, and Chairman effective Oct 19, 2023.
- Preliminary Q3 2023 revenue $33.3M: cell processing $13.3M, storage $6.6M, freezers $13.4M.
- FY2023 revenue guidance narrowed to low end of $144M-$158M range; expects flat to modest Q4 cell processing growth.
- Garrie Richardson, former GM of biostorage and founder of SciSafe, promoted to Chief Revenue Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/834365/000162828023034923/0001628280-23-034923-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/834365/000162828023034923/blfs-20231019.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-034923

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer